source
- Legend Biotech shares first in vivo CAR-T data, its next act after CarvyktiLegend Biotech’s long-awaited first showing of in vivo CAR-T data is here, fueling momentum in the growing field. Legend reported results Tuesday on 12 lymphoma patients from an investigator-initia…Endpoints · 1mo ago↗ source
- FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for PatientsThe U.S. Food and Drug Administration (FDA) today issued draft guidance to help developers bring promising gene therapies to patients more efficiently by making greater use of existing scientific a…fda press · 1mo ago↗ source
- #ASCO26: Celcuity plans another FDA filing after positive breast cancer readoutCelcuity said a combination regimen with its experimental drug gedatolisib doubled patients' likelihood of survival without disease progression or death in a late-stage breast cancer trial. Executi…